Who can use Diacomit(Stiripentol)?

Stiripentol is indicated for the treatment of seizures associated with Dravet syndrome (severe myoclonic epilepsy in infants) in patients aged 6 months and older, weighing 7 kg or more, who are taking clobazam. There are no clinical data to support the use of stiripentol as monotherapy for Dravet syndrome.